As David Patterson observed in 1980, “A RISC potentially gains in speed merely from a simpler design.” Patterson’s principle of simplicity underpins a new alternative to speculation: A deterministic, ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

The Northeast Supply Enhancement pipeline is seeking approval for a certificate that has been denied three times in the past.

A multi-state carbon capture pipeline began operating in September, reducing emissions from Midwest ethanol plants and carrying that ...

The cornerstone program for training and placing student talent into government cybersecurity positions has been hobbled by ...

Florida poised for production surge with new Stage 32 partnership to launch a statewide below-the-line certification program ...

The drug, which Lilly in-licensed four years ago and is designed to inhibit a protein known as P2X7, did not meet the company ...

Before being discontinued, the P2X7 receptor blocker had cleared a master protocol study in chronic pain, though Eli Lilly ...

With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to ...

UNIVERSITY PARK — Rhett Lashlee made a quick, 23-month stop at Miami in between his two stints at SMU — and his time as the ...

In 2019, nurse turnover at NYC Health + Hospitals reached a staggering 46%. Fast forward six years, and that number has dropped to just 7%. In this conversation, Natalia Cineas, DNP, R.N., senior vice ...

Electra Therapeutics has completed an oversubscribed $183 million Series C financing it said will fund a global pivotal trial of its lead pipeline candidate, a frontline treatment for secondary ...